Meds Apotek AB (publ) (OSTO:MEDS) Research & Development: kr0 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OSTO:MEDS Meds Apotek AB (publ) OSTO:MEDS
11 GF Score
Price kr25.20
! 2 Warning Signs
View Full Analysis

What is Meds Apotek AB (publ) Research & Development?

Meds Apotek AB (publ) OSTO:MEDS +18.31% 11 Research & Development is kr0 Mil as of Jun. 2026. GuruFocus rates OSTO:MEDS with a GF Score™ of 11/100. The stock has 2 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Meds Apotek AB (publ)'s Research & Development for the three months ended in Jun. 2026 was kr0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Jun. 2026 was kr0 Mil.

Meds Apotek AB (publ)  (OSTO:MEDS) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Meds Apotek AB (publ) Research & Development Related Terms

Meds Apotek AB (publ) Research & Development Historical Data

* Premium members only.

The historical data trend for Meds Apotek AB (publ)'s Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Meds Apotek AB (publ) Research & Development Chart

Meds Apotek AB (publ) Annual Data
Trend Dec21 Dec23 Dec24 Dec25
Research & Development
0.00 0.00 0.00 0.00

Meds Apotek AB (publ) Quarterly Data
Dec21 Jun22 Dec23 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
OSTO:MEDS
11GF Score
Meds Apotek AB (publ) OSTO:MEDS
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Meds Apotek AB (publ) Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of kr0 Mil mean?
Meds Apotek AB (publ) (OSTO:MEDS) has a Research & Development of kr0 Mil as of Jun. 2026. Research and development expense is the total cost for research and development activities. View historical data on Meds Apotek AB (publ) and its competitors.
Is Meds Apotek AB (publ)'s Research & Development too high?
Meds Apotek AB (publ)'s current Research & Development is kr0 Mil. Overall, Meds Apotek AB (publ) has a GF Score™ of 11/100, reflecting its overall financial health beyond just this single metric.
How does Meds Apotek AB (publ)'s Research & Development compare to AMZN and BABA?
Meds Apotek AB (publ)'s Research & Development of kr0 Mil can be compared against companies in the Retail - Cyclical industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Retail - Cyclical company?
A good Research & Development depends on the Retail - Cyclical industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Meds Apotek AB (publ) and its competitors. Meds Apotek AB (publ)'s current Research & Development is kr0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Meds Apotek AB (publ) stock overvalued right now?
Meds Apotek AB (publ) (OSTO:MEDS) has a current Research & Development of kr0 Mil. The current Research & Development is kr0 Mil. Meds Apotek AB (publ)'s overall GF Score™ is 11/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Meds Apotek AB (publ) (OSTO:MEDS), the current Research & Development is kr0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Meds Apotek AB (publ) Business Description

Address Elektravagen 26, Port 136, Hagersten, Stockholm, SWE, 12630
Meds Apotek AB (publ) is a full-scale online pharmacy that sells prescription and over-the-counter medicines with permission from the Medical Products Agency, the Swedish Food Agency and the E-Health Agency. The company's pharmacy products include everything in health, well-being, dietary supplements, beauty products, children's products, fitness products, food and drink and home & household products.
11GF Score

Get the complete analysis for OSTO:MEDS

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr25.20
Price